A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)

Brief description of study

This study designed to evaluate the long-term efficacy and safety of mirikizumab in participants with moderately to severely active ulcerative colitis (UC).

Clinical Study Identifier: NCT03519945

Start Over

JHCO Tokyo Yamate Medical Center

Shinjuku-ku, Japan

3.41miles

Center Hospital of the National Center for Global Health and Medicine

Shinjuku-ku, Japan

4.29miles

Kyorin University Hospital

Mitaka, Japan

6.23miles

Juntendo University Hospital

Bunkyo-ku, Japan

6.63miles

Tokyo Medical And Dental University Hospital

Bunkyo-ku, Japan

6.81miles

Kitasato University Kitasato Institute Hospital

Minato-Ku, Japan

7.51miles

View all locations